CHA
MRK icon

Carmichael Hill & Associates’s Merck MRK Stock Holding History

Carmichael Hill & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$713K Buy
6,280
+46
+0.7% +$5.46K 0.25% 77
2024
Q2 		$772K Buy
6,234
+185
+3% +$23.8K 0.3% 67
2024
Q1 		$798K Sell
6,049
-46
-0.8% -$5.67K 0.32% 65
2023
Q4 		$664K Sell
6,095
-200
-3% -$20.8K 0.28% 74
2023
Q3 		$648K Hold
6,295
– – 0.3% 70
2023
Q2 		$726K Sell
6,295
-966
-13% -$110K 0.32% 66
2023
Q1 		$772K Sell
7,261
-261
-3% -$28.2K 0.37% 63
2022
Q4 		$835K Sell
7,522
-287
-4% -$29.3K 0.43% 55
2022
Q3 		$673K Buy
7,809
+313
+4% +$27.9K 0.36% 65
2022
Q2 		$683K Buy
7,496
+452
+6% +$40.1K 0.36% 66
2022
Q1 		$578K Sell
7,044
-711
-9% -$56.1K 0.27% 78
2021
Q4 		$594K Buy
7,755
+15
+0.2% +$1.2K 0.27% 83
2021
Q3 		$581K Buy
7,740
+61
+0.8% +$4.64K 0.29% 72
2021
Q2 		$597K Sell
7,679
-369
-5% -$27.4K 0.3% 69
2021
Q1 		$592K Sell
8,048
-157
-2% -$11.6K 0.33% 64
2020
Q4 		$640K Hold
8,205
– – 0.38% 56
2020
Q3 		$649K Hold
8,205
– – 0.43% 52
2020
Q2 		$605K Hold
8,205
– – 0.44% 49
2020
Q1 		$602K Sell
8,205
-52
-0.6% -$4.09K 0.53% 50
2019
Q4 		$717K Buy
8,257
+117
+1% +$9.61K 0.51% 50
2019
Q3 		$654K Buy
8,140
+106
+1% +$8.49K 0.65% 48
2019
Q2 		$643K Sell
8,034
-209
-3% -$16K 0.64% 46
2019
Q1 		$654K Hold
8,243
– – 0.68% 45
2018
Q4 		$601K Sell
8,243
-62
-0.7% -$4.38K 0.69% 45
2018
Q3 		$562K Sell
8,305
-230
-3% -$14.7K 0.54% 59
2018
Q2 		$494K Hold
8,535
– – 0.53% 62
2018
Q1 		$444K Buy
8,535
+263
+3% +$14.2K 0.49% 64
2017
Q4 		$444K Buy
+8,272
New +$459K 0.49% 66

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Carmichael Hill & Associates's MRK Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Merck (MRK) stake by 0.74% in Q3 2024, buying an estimated $5.46K and bringing the position to 6,280 shares worth $713K. The position accounts for 0.25% of the portfolio, ranked #77.

Carmichael Hill & Associates first reported a position in MRK in Q4 2017 and has held it in 28 quarters since. The position peaked at $835K in Q4 2022. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Carmichael Hill & Associates held 6,280 shares of Merck worth $713K as of Q3 2024.
  • Carmichael Hill & Associates bought 46 Merck shares in Q3 2024, an estimated $5.46K.
  • Merck made up 0.25% of Carmichael Hill & Associates's portfolio in Q3 2024, its #77 holding.
  • Carmichael Hill & Associates first reported a position in Merck in Q4 2017 and has held it in 28 quarters since.
  • Carmichael Hill & Associates's Merck position peaked at $835K in Q4 2022.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.